Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
NCT ID: NCT03731130
Last Updated: 2018-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2018-10-05
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer
NCT00597311
Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma
NCT01325649
Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
NCT04095468
Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients
NCT02321813
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neoadjuvant short term radiation
Treatment with neoadjuvant short term radiation therapy (5x5 Gy) followed by surgery. Quality of life will be assessed using the EORTC QLQ C30 and EORTC QLQ CR 29 questionaire.
EORTC QLQ C30
standardized questionaire
EORTC QLQ CR29
standardized questionaire
neoadjuvant long-term chemoradiation
Treatment with neoadjuvant Long-term chemoradiation followed by surgery. Quality of life will be assessed using the EORTC QLQ C30 and EORTC QLQ CR 29 questionaire
EORTC QLQ C30
standardized questionaire
EORTC QLQ CR29
standardized questionaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EORTC QLQ C30
standardized questionaire
EORTC QLQ CR29
standardized questionaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation
* age \>=18 years
* written informed consent
* ability to answer the standardized questionaires according to the treating physician
Exclusion Criteria
* prior systemic therapy with regard to rectal Cancer
* distant metastasis
* second malignancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Falk Roeder
Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Falk Roeder, MD
Role: PRINCIPAL_INVESTIGATOR
Ludwig-Maximilians Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V1 10.07.2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.